Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
MPEDE-PKD is a clinical trial looking to recruit 300 participants in the UK for a randomised placebo-controlled trial of Metformin XR 500mg. We are looking for bidders who have the capability to purchase or manufacture Metformin and an identical placebo, package and label them to our requirements and distribute to 35-40 NHS Trusts across the UK
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Sharp Clinical Services (UK) Ltd | 02234557 | ~£400,000 estimated from lot values | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 4 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 1,500 days (≈4.1 yrs) | £400,000 | 4 | Sharp Clinical Services (UK) Ltd | active |
Weightings from the notice.
Government spending data: This supplier has received £150,000 in 1 payments (over £25k) from Welsh Government (2021-02-11 to 2021-02-11). View full payment history →
Changes the buyer published to this notice after it first appeared.
Please note amendment to II.2.5.1.1 - Award criteria.This should read Price is not the only award criterion and all criteria are stated only in the procurement documents